Results 71 to 80 of about 6,002 (227)

A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol

open access: yesBMC Palliative Care
Background Emerging randomized data, mostly from phase II trials, have suggested that patients with oligometastatic cancers may benefit from ablative treatments such as stereotactic ablative radiotherapy (SABR).
David A. Palma   +25 more
doaj   +1 more source

Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer

open access: yesInternational Journal of Breast Cancer, 2018
Stereotactic ablative body radiotherapy (SABR) has a role as definitive therapy in many tumor sites; however, its role in the treatment of breast cancer is less well explored.
Aisling Barry, Anthony Fyles
doaj   +1 more source

Evolution of Hypofractionated Accelerated Radiotherapy for Prostate Cancer – The Sunnybrook Experience

open access: yesFrontiers in Oncology, 2014
Stereotactic Ablative Body Radiotherapy (SABR) is a newer method of ultra hypo fractionated radiotherapy that uses combination of image guided radiotherapy (IGRT) and intensity modulated radiotherapy(IMRT) or volumetric modulated arc therapy(VMAT), to ...
Hima Bindu Musunuru   +6 more
doaj   +1 more source

Phase I trial of carboplatin and gemcitabine chemotherapy and stereotactic ablative radiosurgery for the palliative treatment of persistent or recurrent gynecologic cancer

open access: yesFrontiers in Oncology, 2015
Background: We conducted a phase I trial to determine the safety of systemic chemotherapy prior to abdominopelvic robotic stereotactic ablative radiotherapy (SABR) in women with persistent or recurrent gynecologic cancers. Methods: Patients were assigned
Charles A Kunos   +8 more
doaj   +1 more source

Population Analysis of SABR/SRS for the Treatment of Metastatic Cancer in a Jurisdiction of 15 Million People [PDF]

open access: bronze, 2023
Jason Pantarotto   +4 more
openalex   +1 more source

Stereotactic ablative radiotherapy for primary renal cell carcinoma

open access: yesClinical and Translational Radiation Oncology
Stereotactic ablative radiotherapy (SAbR) is an emerging non-invasive definitive treatment option for primary renal cell carcinoma (RCC), particularly when surgery is not ideal.
Daniel X. Yang   +3 more
doaj   +1 more source

Splenic Irradiation and Late Volume Changes Following Stereotactic Ablative Radiotherapy (SABR) for Adrenal Tumors [PDF]

open access: bronze, 2023
Nicolas Giraud   +4 more
openalex   +1 more source

Partial Stereotactic Ablative Radiotherapy Boost Before Conventional Radiotherapy (P‐SABR) for Large (> 5 cm) Unresectable Stage III Nonsmall Cell Lung Cancer

open access: yesThoracic Cancer
Objective Stereotactic ablative radiotherapy (SABR) is renowned for its high local control (LC) rates. Nonetheless, for tumors that are either large in volume or in close proximity to critical organs at risk, the application of SABR to the entire tumor ...
Yun Bai   +15 more
doaj   +1 more source

SABRe: Affordances, Realizations and Perspectives

open access: yes, 2012
+ ID: 549335 + PeerReviewed: Peer ...
Schiesser Sébastien, Schacher Jan
openaire   +2 more sources

Home - About - Disclaimer - Privacy